Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 14,101–14,125 of 27,380 studies, newest first · page 565 of 1096.

April 2018 25

  1. 2018-04-05

    Stress Granule Assembly Disrupts Nucleocytoplasmic Transport

    ✓ Peer-reviewed Lewy body dementia Cell

    Key finding: Our findings identify a link between stress granule assembly and nucleocytoplasmic transport, two fundamental cellular processes implicated in the pathogenesis of C9ORF72-mediated ALS/FTD and other neurodegenerative diseases.

  2. 2018-04-04

    Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association

    ✓ Peer-reviewed Prevention trials Circulation

    Key finding: Physical inactivity is one of the most prevalent major health risk factors, with 8 in 10 US adults not meeting aerobic and muscle-strengthening guidelines, and is associated with a high burden of cardiovascular disease. +1 more finding

  3. 2018-04-04

    Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

    ✓ Peer-reviewed Tau biomarkers Alzheimer s & Dementia

    Plasma pTau181 may have utility as a biomarker of AD pathophysiology and as a noninvasive screener for elevated brain Aβ.

  4. 2018-04-04

    TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease

    ✓ Peer-reviewed TREM2 and immune genetics Biochemical and biophysical research communications

    Key finding: Furthermore, microglia could polarize into classic inflammatory M1 and immunosuppressive M2 phenotype. +3 more findings

  5. 2018-04-03

    The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Brain research

    Key finding: Many studies have suggested that amyloid beta (Aβ) peptides have a pivotal role in AD progression, by mitochondrial dysfunction of neuronal cells. +4 more findings

  6. 2018-04-02

    The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease

    ✓ Peer-reviewed Drug development The Journal of pathology

    Key finding: The results illuminate mechanisms of neuroprotection by liraglutide, and indicate that GLP-1 receptor activation may be harnessed to protect brain insulin receptors and synapses in AD. © 2018 The Authors.

  7. 2018-04-02

    Motor and Cognitive Trajectories Before Dementia: Results from Gait and Brain Study

    ✓ Peer-reviewed Cognitive tests and assessment Journal of the American Geriatrics Society

    Key finding: Prospective cohort study with 5 years of follow-up. +3 more findings

  8. 2018-04-02

    Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases

    ✓ Peer-reviewed Getting a diagnosis Cold Spring Harbor perspectives in biology

    Key finding: Most clinicians who care for the elderly are not trained to diagnose these conditions, perhaps other than typical Alzheimer's disease (AD). +4 more findings

  9. 2018-04-02

    Effects of Exercise on Vascular Function, Structure, and Health in Humans

    ✓ Peer-reviewed Prevention and risk Cold Spring Harbor perspectives in medicine

    Key finding: The clinical implications of these physiological adaptations are profound. +4 more findings

  10. 2018-04-01

    Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types

    ✓ Peer-reviewed Genetics Nature Genetics

    Key finding: Our results demonstrate that our polygenic approach is a powerful way to leverage gene expression data for interpreting GWAS signal.

  11. 2018-04 month only

    Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes

    ✓ Peer-reviewed Brain scans and imaging Clinical nuclear medicine

    Key finding: Among the 12 patients with PPA syndrome, 8 (66.7%) were considered as amyloid positive. +4 more findings

  12. 2018-04-01

    An epigenetic biomarker of aging for lifespan and healthspan

    ✓ Peer-reviewed Disease mechanisms Aging

    Key finding: Based on an in-depth transcriptional analysis in sorted cells, we find that increased epigenetic, relative to chronological age, is associated with increased activation of pro-inflammatory and interferon pathways, and decreased activation of transcriptional/translational machinery, DNA damage response, and mitochondrial signatures. +1 more finding

  13. 2018-04-01

    Neuronal Cell Death

    ✓ Peer-reviewed Inflammation and the immune system Physiological reviews

    Key finding: However, we now know that there are at least a dozen ways for neurons to die, that blocking a particular mechanism of cell death may not prevent the cell from dying, and that non-neuronal cells also contribute to neuronal death. +4 more findings

  14. 2018-04-01

    Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease

    ✓ Peer-reviewed Treatments Neural regeneration research

    Key finding: Curcumin was developed as an early diagnostic probe based on its natural fluorescence and high binding affinity to amyloid-β. +4 more findings

  15. 2018-04-01

    FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: Age-related hippocampal sclerosis may account for a significant proportion of elderly participants with amnestic dementia. +3 more findings

  16. 2018-04-01

    Label-free detection of β-amyloid peptides (Aβ40 and Aβ42): a colorimetric sensor array for plasma monitoring of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Nanoscale

    Key finding: Different aggregation behaviors of nanoparticles through their conjugation with Aβ42 and Aβ40 followed by the coordination of Aβ42 and Aβ40 with Cu(ii) led to diverse spectral and color changes. +4 more findings

  17. 2018-04-01

    Unrecognized Cardiovascular Emergencies Among Medicare Patients

    ✓ Peer-reviewed End-of-life care JAMA internal medicine

    Key finding: There were 1 561 940 patients, including 17 963 hospitalized for ruptured AAA, 304 980 for AMI, 1 181 648 for stroke, 19 675 for aortic dissection, and 37 674 for SAH. +2 more findings

  18. 2018-04-01

    Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention

    ✓ Peer-reviewed Disease mechanisms Neural regeneration research

    Key finding: A significant contributing factor to the progression of the disease appears to be the progressive accumulation of amyloid-β42 (Aβ42), a small hydrophobic peptide. +1 more finding

  19. 2018-04-01

    The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States

    ✓ Peer-reviewed Prevention and risk The journals of gerontology. Series B, Psychological sciences and social sciences

    Key finding: Prevention of chronic disease may generate health and longevity benefits but does not reduce burden of dementia. +1 more finding

  20. 2018-04-01

    Cerebral Microbleeds: Imaging and Clinical Significance

    ✓ Peer-reviewed Brain tissue and pathology Radiology

    Key finding: CMBs are detected with increasing frequency because of the more widespread use of high magnetic field strength and of newer dedicated MR imaging techniques such as three-dimensional gradient-echo T2*-weighted and SW imaging. +3 more findings

  21. 2018-04-01

    Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation

    ✓ Peer-reviewed Lewy body dementia Cell

    Key finding: Our findings reveal two regulatory mechanisms of liquid-phase homeostasis that are disrupted in FUS-associated neurodegeneration.

  22. 2018-04-01

    FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions

    ✓ Peer-reviewed Lewy body dementia Cell

    Key finding: Indeed, significant hypomethylation, which occurs in FUS-associated frontotemporal lobar degeneration (FTLD), induces FUS condensation into stable intermolecular β-sheet-rich hydrogels that disrupt RNP granule function and impair new protein synthesis in neuron terminals. +1 more finding

  23. 2018-04-01

    Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease

    ✓ Peer-reviewed Brain scans and imaging JAMA neurology

    Key finding: However, the extent to which increasing age, Aβ, and ε4 are associated with memory decline remains unclear, and the age at which memory decline begins for Aβ-positive ε4 carriers and noncarriers has not been determined. +4 more findings

  24. 2018-04-01

    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We envision that defining AD as a biological construct will enable a more accurate characterization and understanding of the sequence of events that lead to cognitive impairment that is associated with AD, as well as the multifactorial etiology of dementia.

  25. 2018-04-01

Browse the library by subject, with the full score breakdown →